
|Videos|July 3, 2017
Is One Immunotherapy for Lung Cancer Better Than the Rest?
Author(s)Melissa L. Johnson, MD
This video reviews immunotherapy options now available for the treatment of lung cancer across different lines of therapy.
Advertisement
In this video, Melissa L. Johnson, MD, of Sarah Cannon Research Institute in Nashville, Tennessee, reviews immunotherapy options now available for the treatment of lung cancer across different lines of therapy and highlights upcoming research in this setting.
Johnson gave a presentation on this topic during an education session at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting last month in Chicago.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
Sacituzumab Govitecan Combo Reduces Progression, Death By 35% in Metastatic TNBC
2
FDA Approves Liquid Biopsy CDx for Encorafenib Regimen in BRAF V600E+ CRC
3
Median OS Not Yet Reached With New Immunotherapy Combo in 2L Glioblastoma
4
Decoding the Top Moments in Prostate Cancer Management From 2025
5




































